ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

ClinicalTrials.gov ID: NCT05550532

Public ClinicalTrials.gov record NCT05550532. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 10:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

Study identification

NCT ID
NCT05550532
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
444 participants

Conditions and interventions

Interventions

  • Aticaprant Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 74 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 5, 2022
Primary completion
Nov 7, 2024
Completion
Nov 12, 2024
Last update posted
Feb 12, 2026

2022 – 2024

United States locations

U.S. sites
51
U.S. states
19
U.S. cities
43
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35205
Sunwise Clinical Research Lafayette California 94549
Pacific Neuropsychiatric Specialists Orange California 92868
Prospective Research Innovations Inc Rancho Cucamonga California 91730
University of California San Diego Medical Center San Diego California 92103
CMB Clinical Trials Santee California 92071
California Neuroscience Research Sherman Oaks California 91403
Pacific Clinical Research Medical Group Upland California 91786
Next Level Clinical Trials, LLC West Covina California 91790
MCB Clinical Research Centers LLC Colorado Springs Colorado 80910
CNS Clinical Research Group Coral Springs Florida 33067
Sarkis Clinical Trials Gainesville Florida 32607
New Life Medical Research Center, Inc. Hialeah Florida 33012
K2 Medical Research Maitland Florida 32751
Vital Care Research Miami Florida 33122
Global Medical Institutes Miami Florida 33125
LCC Medical Research Institute Inc Miami Florida 33126
Florida Research Center Inc. Miami Florida 33174
Ezy Medical Research Miami Florida 33175
Felicidad Medical Research Miami Florida 33184
Bravo Health Care Center North Bay Village Florida 33141
APG Research LLC Orlando Florida 32803
Combined Research Orlando Orlando Florida 32803
Quantum Laboratories Pompano Beach Florida 33064
CDC Research Institute LLC Port Saint Lucie Florida 34952
Psychiatric Medicine Associates Skokie Illinois 60076
Tandem Clinical Research Marrero Louisiana 70072
CBH Health Gaithersburg Maryland 20877
Michigan Clinical Research Institute Ann Arbor Michigan 48105
Revive Research Institute Farmington Hills Michigan 48334
Midwest Research Group Saint Charles Missouri 63304
Premier Psychiatric Research Institute, LLC Lincoln Nebraska 68526
Erie County Medical Center Buffalo New York 14215
Manhattan Behavioral Medicine New York New York 10036
New Hope Clinical Research Charlotte North Carolina 28211
Monroe Biomedical Research Monroe North Carolina 28112
The Cleveland Clinic Foundation Cleveland Ohio 44195
Wexner Medical Center at the Ohio State University Columbus Ohio 43221
Conrad Clinical Research Edmond Oklahoma 73013
Sooner Clinical Research Oklahoma City Oklahoma 73112
Paradigm Research Professionals, LLC Oklahoma City Oklahoma 73118
Lehigh Center for Clinical Research LLC Allentown Pennsylvania 18103
Global Medical Institutes Moosic Pennsylvania 18507
Clinical Trials of South Carolina Charleston South Carolina 29406
Donald J Garcia Jr MD PA Austin Texas 78737
Relaro Medical Trials Dallas Texas 75243
UT Southwestern Medical Center Dallas Texas 75247-9119
R and H Clinical Research Stafford Texas 77477
Cedar Psychiatry Murray Utah 84107
Northwest Clinical Research Center Bellevue Washington 98007
Core Clinical Research Everett Washington 98201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 80 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05550532, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 12, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05550532 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →